{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:49:01Z","timestamp":1784202541585,"version":"3.55.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":3948,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.farma.2010.09.008","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T12:30:37Z","timestamp":1308486637000},"page":"217-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Necr\u00f3lisis epid\u00e9rmica t\u00f3xica con desenlace fatal causada por el uso concomitante de carbamazepina, cilostazol y omeprazol: A prop\u00f3sito de un caso"],"prefix":"10.1016","volume":"35","author":[{"given":"I.","family":"Concepci\u00f3n Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Fern\u00e1ndez de Palencia Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Garrido Corro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De La Rubia Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2010.09.008_bib0005","first-page":"541","article-title":"Necrolisis epid\u00e9rmica t\u00f3xica y s\u00edndrome de Stevens-Johnson: clasificaci\u00f3n y actualidad terap\u00e9utica","volume":"91","author":"Garc\u00eda Doval","year":"2000","journal-title":"Actas Dermosifiliogr"},{"issue":"6 Pt 1","key":"10.1016\/j.farma.2010.09.008_bib0010","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"Am Acad Dermatol"},{"key":"10.1016\/j.farma.2010.09.008_bib0015","unstructured":"Ficha t\u00e9cnica de Tegretol\u00ae 200mg comprimidos. Novartis Farmac\u00e9utica; 9 de marzo de 2009."},{"key":"10.1016\/j.farma.2010.09.008_bib0020","unstructured":"Ficha t\u00e9cnica de Ekistol\u00ae 100mg comprimidos. Lacer; octubre de 2008."},{"key":"10.1016\/j.farma.2010.09.008_bib0025","unstructured":"Ficha t\u00e9cnica de Omeprazol Sandoz\u00ae 20mg c\u00e1psulas. Sandoz Farmac\u00e9utica; noviembre de 2008."},{"issue":"Suppl 2","key":"10.1016\/j.farma.2010.09.008_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00003088-199937002-00006","article-title":"Effect of omeprazole on the metabolism of cilostazol","volume":"37","author":"Suri","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.farma.2010.09.008_bib0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF02282329","article-title":"Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients with h. pylori gastritis (letter)","volume":"41","author":"Dammann","year":"1996","journal-title":"Dig Dis Sci"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634311000584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634311000584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:16:14Z","timestamp":1761106574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634311000584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1130634311000584"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2010.09.008","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necr\u00f3lisis epid\u00e9rmica t\u00f3xica con desenlace fatal causada por el uso concomitante de carbamazepina, cilostazol y omeprazol: A prop\u00f3sito de un caso","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2010.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 SEFH. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}